The new clinical frontier is hybrid peptides. These engineered molecules merge portions derived from various amino acid families, facilitating the development of novel therapeutic characteristics. The strategy offers a https://chimerapeptides786194.wikiconversation.com/8454828/chimera_peptides_a_novel_therapeutic_frontier